Vol 37, Issue 3

When Baby and OCD Are on Board Assessment and Treatment Issues

March 31, 2020

OCD in the general population often differs from OCD that presents in the perinatal period. It is imperative to recognize, assess, and treat perinatal OCD to improve maternal and child outcomes and have a transgenerational impact.

Treatment Nonadherence: An Epidemic Hidden in Plain Sight

March 27, 2020

A number of factors affect treatment adherence, including the therapeutic alliance, perceived perceived lack of control, risk of dependence on medications, stigma associated with medication use, and more.

Dear Provider

March 24, 2020

I read Dear Provider in a letter from a health care company. Provider is a fine word, and I’ve always felt proud to provide for my family-but the company doesn’t know guys from Jersey are sensitive.

Managing Behavioral and Psychological Symptoms of Dementia

March 20, 2020

BPSD is associated with worse outcomes for patients with dementia. Management is not standardized, but protocols generally involve the treatment of underlying symptoms followed by the use of nonpharmacological management techniques and evidence-based pharmacotherapy for refractory BPSD.

Reframing Our Relationship With Pharma

March 19, 2020

It can be disheartening to hear about the pervasive culture at many medical centers and health care systems to ostracize the pharmaceutical industry, and not uncommonly, to threaten to fire employed physicians and clinicians who would like to attend educational programs about new medications on their own free time.

The New Game of Microbiology Clue: The Who, When, Where, and Why of the Novel Coronavirus

March 16, 2020

Psychiatrists must have a basic understanding of the pathophysiology of coronaviruses in order to be able to accurately explain and discuss those issues with their patients, especially as mental health ramifications are expected.